Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Net Change in Cash

Iovance Biotherapeutics Inc Net Change in Cash Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Net Change in Cash from 2010 to 2020.
  • Iovance Biotherapeutics Inc Net Change in Cash for the quarter ending June 06, 2020 was $108m a 135.18% increase of 146m year over year
  • Iovance Biotherapeutics Inc Net Change in Cash for the last 12 months ending June 06, 2020 was $84m a 143.45% increase of 120m year over year
  • Iovance Biotherapeutics Inc Annual Net Change in Cash for 2019 was $-63m a -0.78% increase of 0m from 2018
  • Iovance Biotherapeutics Inc Annual Net Change in Cash for 2018 was $-63m a 161.14% decrease of -102m from 2017
  • Iovance Biotherapeutics Inc Annual Net Change in Cash for 2017 was $39m a -89.18% decrease of -34m from 2016
Other Cash Flow Metrics:
  • Iovance Biotherapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-28m a 24.94% decrease of -7m year over year
  • Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-16m a 52.18% decrease of -9m year over year
View Chart On Koyfin

Quarterly IOVA Net Change in Cash Data

06/2020$108m
03/2020$39m
12/2019$-25m
09/2019$-38m
06/2019$28m
03/2019$-28m
12/2018$1m
09/2018$-165m
06/2018$-51m
03/2018$152m

Annual IOVA Net Change in Cash Data

2019$-63m
2018$-63m
2017$39m
2016$73m
2015$-11m
2014$25m
2013$20m
2012$-1m
2011$-1m
2010$1m